| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.008 | 0.9 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |